首页> 外文OA文献 >Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

【2h】

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

机译：抗CD22免疫毒素Moxetumab对儿童急性淋巴细胞白血病的抗CD22免疫毒素Moxetumab的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alan S. Wayne; Nirali N. Shah; Deepa Bhojwani; Lewis B. Silverman; James A. Whitlock; Maryalice Stetler-Stevenson; Weili Sun; Meina Liang; Jie Yang; Robert J. Kreitman; Mark C. Lanasa; Ira Pastan;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia [J] . Wayne Alan S., Shah Nirali N., Bhojwani Deepa, Blood: The Journal of the American Society of Hematology . 2017,第14期

机译：第1期抗CD22免疫毒素MoxetumoMab对儿童急性淋巴细胞白血病的研究
2. Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia. [J] . Robert J Kreitman, Martin S Tallman, Tadeusz Robak, Journal of Clinical Oncology . 2012,第15期

机译：毛细胞白血病患者抗CD22重组免疫毒素Moxetumomab Pasudotox（CAT-8015或HA22）的I期试验。
3. Molecular Remissions with Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox Are Associated with Improved Complete Remission Durations during Phase I and III Testing [J] . Arons Evgeny, Gorelik Daniel, Stetler-Stevenson Maryalice, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：抗CD22重组免疫毒素Moxetumomab毒水杆蛋白的分子除降与III和III期测试期间改善的完整缓解持续时间有关
4. Machine Learning Approach to Predict the Survival Time of Childhood Acute Lymphoblastic Leukemia Patients [C] . Rangana Jayashanka, C.R. Wijesinghe, A.R. Weerasinghe, International Conference on Advances in ICT for Emerging Regions . 2018

机译：机器学习方法预测儿童急性淋巴细胞白血病患者的生存时间
5. The Role of Infections in the Etiology of Childhood Acute Lymphoblastic Leukemia [D] . Hwee, Jeremiah 2018

机译：感染在儿童急性淋巴细胞白血病的病因中的作用
6. Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia [O] . Alan S. Wayne, Nirali N. Shah, Deepa Bhojwani, -1

机译：抗CD22免疫毒素Moxetumomab假单抗治疗儿童急性淋巴细胞白血病的1期研究
7. A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox (HA22, CAT-8015): Activity in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT) [O] . Shah N.N., Bhojwani D., Silverman L.B., 2012

机译：新型抗CD22免疫毒素，Moxetumomab Pasudotox（HA22，CAT-8015）：异基因造血干细胞移植（SCT）后复发性急性淋巴细胞白血病（ALL）小儿患者的活性

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

著录项

引文网络

相似文献

相关主题

期刊订阅